367 related articles for article (PubMed ID: 21851624)
1. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1.
Dong P; Kaneuchi M; Watari H; Hamada J; Sudo S; Ju J; Sakuragi N
Mol Cancer; 2011 Aug; 10():99. PubMed ID: 21851624
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.
Li F; Liang A; Lv Y; Liu G; Jiang A; Liu P
Med Sci Monit; 2017 Oct; 23():5139-5149. PubMed ID: 29080395
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of microRNA-194 suppresses the epithelial-mesenchymal transition in targeting stem cell transcription factor Sox3 in endometrial carcinoma stem cells.
Gong B; Yue Y; Wang R; Zhang Y; Jin Q; Zhou X
Tumour Biol; 2017 Jun; 39(6):1010428317706217. PubMed ID: 28618953
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.
Dong P; Kaneuchi M; Watari H; Sudo S; Sakuragi N
Mol Carcinog; 2014 May; 53(5):349-59. PubMed ID: 24002805
[TBL] [Abstract][Full Text] [Related]
5. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J
Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N
Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121
[TBL] [Abstract][Full Text] [Related]
7. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.
Guo BH; Feng Y; Zhang R; Xu LH; Li MZ; Kung HF; Song LB; Zeng MS
Mol Cancer; 2011 Jan; 10(1):10. PubMed ID: 21276221
[TBL] [Abstract][Full Text] [Related]
8. MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4.
Zhao X; Dai L; Yue Q; Wang H; Wang XU; Li Y; Chen R
J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894127
[TBL] [Abstract][Full Text] [Related]
9. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
10. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells.
Song LB; Li J; Liao WT; Feng Y; Yu CP; Hu LJ; Kong QL; Xu LH; Zhang X; Liu WL; Li MZ; Zhang L; Kang TB; Fu LW; Huang WL; Xia YF; Tsao SW; Li M; Band V; Band H; Shi QH; Zeng YX; Zeng MS
J Clin Invest; 2009 Dec; 119(12):3626-36. PubMed ID: 19884659
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-183 induces epithelial-mesenchymal transition and promotes endometrial cancer cell migration and invasion in by targeting CPEB1.
Xiong H; Chen R; Liu S; Lin Q; Chen H; Jiang Q
J Cell Biochem; 2018 Nov; 119(10):8123-8137. PubMed ID: 29923214
[TBL] [Abstract][Full Text] [Related]
12. MiR-200a promotes epithelial-mesenchymal transition of endometrial cancer cells by negatively regulating FOXA2 expression.
Shi W; Wang X; Ruan L; Fu J; Liu F; Qu J
Pharmazie; 2017 Nov; 72(11):694-699. PubMed ID: 29442045
[TBL] [Abstract][Full Text] [Related]
13. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
[TBL] [Abstract][Full Text] [Related]
14. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.
Castilla MÁ; Moreno-Bueno G; Romero-Pérez L; Van De Vijver K; Biscuola M; López-García MÁ; Prat J; Matías-Guiu X; Cano A; Oliva E; Palacios J
J Pathol; 2011 Jan; 223(1):72-80. PubMed ID: 21125666
[TBL] [Abstract][Full Text] [Related]
15. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.
Godlewski J; Nowicki MO; Bronisz A; Williams S; Otsuki A; Nuovo G; Raychaudhury A; Newton HB; Chiocca EA; Lawler S
Cancer Res; 2008 Nov; 68(22):9125-30. PubMed ID: 19010882
[TBL] [Abstract][Full Text] [Related]
16. miR-326 regulates EMT and metastasis of endometrial cancer through targeting TWIST1.
Liu W; Zhang B; Xu N; Wang MJ; Liu Q
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3787-3793. PubMed ID: 28975990
[TBL] [Abstract][Full Text] [Related]
17. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA-ATB Impairs the Function of Tumor Suppressor miR-126-Mediated Signals in Endometrial Cancer for Tumor Growth and Metastasis.
Zheng X; Liu M; Song Y; Feng C
Cancer Biother Radiopharm; 2019 Feb; 34(1):47-55. PubMed ID: 30601064
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer.
Xu Q; Sun Q; Zhang J; Yu J; Chen W; Zhang Z
Carcinogenesis; 2013 Mar; 34(3):539-49. PubMed ID: 23188671
[TBL] [Abstract][Full Text] [Related]
20. Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing.
Jiang FZ; He YY; Wang HH; Zhang HL; Zhang J; Yan XF; Wang XJ; Che Q; Ke JQ; Chen Z; Tong H; Zhang YL; Wang FY; Li YR; Wan XP
Oncotarget; 2015 Dec; 6(42):44660-74. PubMed ID: 26587974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
